Sema.jpg
Sema4 Launches Sema4 Elements™, a Portfolio of Data Science-Driven Products and Services to Support Reproductive and Generational Health
09 sept. 2021 08h00 HE | Sema4
STAMFORD, Conn., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Sema4, an AI-driven genomic and clinical data intelligence platform company, today announced the launch of Sema4 Elements™, a portfolio of...
Sema.jpg
Avera Health and Sema4 Announce Collaboration to Advance Precision Oncology Care
11 août 2021 08h00 HE | Sema4
SIOUX FALLS, S.D and STAMFORD, Conn., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Avera Health, an integrated regional health care system that serves 300 locations across the Upper Midwest, and Sema4, a...
Sema.jpg
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company
22 juil. 2021 09h15 HE | Sema4
Sema4 Holdings Corp (“Sema4”) to debut on Nasdaq as a publicly traded company dedicated to transforming healthcare by applying artificial intelligence and machine learning to multidimensional,...
SomaLogic launches t
SomaLogic launches the SomaSignal™ Proteomics for Precision Medicine Initiative with healthcare innovators: Emory University, Intermountain Healthcare, CommonSpirit Health and UCHealth
20 mai 2021 10h00 HE | SomaLogic, Inc.
BOULDER, Colo., May 20, 2021 (GLOBE NEWSWIRE) -- SomaLogic announced today its SomaSignal™ Proteomics for Precision Medicine Initiative, the first large-scale, clinically focused partnership effort...
logo big square.png
Syapse Announces Research Collaboration with the FDA Focused on the Regulatory Use of Real-World Evidence
14 août 2019 06h00 HE | Syapse
SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement...